CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 15 enrolled
Drug / intervention
Escitalopram +1 moredrug
Likely dose
Escitalopram 10 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00872027
NCT00872027Phase 4Completed
CompareCT.gov

Feasibility Study to Prevent Post-ICU Depression

University of Minnesota·interventional·Posted Mar 31, 2009·Updated Dec 19, 2017

In Brief

A Phase 4 clinical trial evaluating Escitalopram and Placebo for Depression. Completed, enrolled 15 participants across 1 site.

Detailed Summary

This study will determine the effectiveness of antidepressant medication in preventing depression and improving recovery in people who have been supported by mechanical ventilators in an intensive care unit (ICU).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 31, 2009
Enrollment StartApr 1, 2009
Primary CompletionApr 1, 2011
Study CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 17.3 years ago

Interventions

Escitalopramdrug

10 mg of escitalopram administered enterally with the option for dose escalation to 20 mg after 3 to 5 weeks if the medical condition is stable and no liver disease presents

Placebodrug

Placebo pills for 8 weeks